Back to News
Market Impact: 0.25

The S&P 500 Was Up in January. Here's What History Says Happens for the Rest of the Year.

NFLXNVDANDAQ
Market Technicals & FlowsInvestor Sentiment & PositioningAnalyst Insights
The S&P 500 Was Up in January. Here's What History Says Happens for the Rest of the Year.

The S&P 500 rose 1.4% in January 2026, and historical analysis of the past 40 years shows that a positive January has preceded a full-year gain roughly 84% of the time with an average full-year return near 15%; when January was positive, the following 11 months were higher 80% of the time with an average Feb–Dec gain of ~11% (median >14%). Conversely, a negative January has led to much weaker full-year outcomes (average full-year return ~2–3%, positive only ~60% of the time), with notable downside years including 2000, 2002, 2008 and 2022; 2018 was a rare instance where January was positive but the rest of the year finished negative.

Analysis

Market structure: A positive January historically concentrates inflows into large-cap risk-on assets (S&P, semiconductors, cyclicals). Winners: mega-cap growth (NVDA, NFLX), S&P ETFs (SPY, IVV) and cyclical small/mid caps as beta demand rises; losers: long-duration bonds (TLT), utilities (XLU) and high-quality defensives as yield/hazard trades compress. Cross-asset: expect modest rise in yields (20–50 bps tail), lower implied equity vols (VIX down toward 12–14), USD weakness on risk-on, and upward pressure on industrial/energy commodities if cycle confirmation arrives. Risk assessment: Key tail risks include a Fed-hawk surprise (terminal rate repricing), China/geo shocks, or a concentrated tech draw that cascades via ETF/option gamma; probability ~10–20% but impact severe. Immediate (days): momentum can persist but is fragile around macro prints; short-term (weeks/months): earnings and CPI (next 30–60 days) will determine durability; long-term (quarters): corporate capex and margin trajectories matter. Hidden dependency: ETF flow concentration into a few names creates liquidity and crowding risks (NVDA/NFLX dominance). Trade implications: Tactical overweight S&P beta and semis while funding with bond defensives—use defined-risk option structures. Direct plays: small long NVDA with protective puts or call spreads ahead of earnings; pair trades: long IWM vs short TLT to express risk-on; options: buy 1–3 month SPX protective puts if VIX <14, sell OTM call spreads to finance bullish exposure. Contrarian angles: The January barometer is correlation, not causation—2018 and 2011 show positive Jan can still end poorly if breadth fails. Current rally is narrow: monitor advance-decline divergence and ETF net inflows; if breadth doesn’t confirm within 4–6 weeks, cut exposure. Crowded ETF/option positioning can invert quickly, creating 5–15% drawdowns in mega-caps.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.35

Ticker Sentiment

NDAQ0.00
NFLX0.80
NVDA0.90

Key Decisions for Investors

  • Establish a 2–3% portfolio long in SPY within the next 10 trading days to capture January momentum; scale out half at +8% and fully exit if 10-year yield rises >30 bps from current level or advance-decline line falls below its 50-day MA.
  • Initiate a 0.5–1% position in NVDA (ticker NVDA) using a 3-month 5% ITM call + 20% OTM call sell (call spread) or buy 3-month 10% OTM protective puts sized to cap downside at ~8–12%; reassess around next earnings (expected within 30–45 days).
  • Implement a pair trade: long IWM 1.5% vs short TLT 1% (equal notional) to express risk-on funded by bond weakness; unwind if Russell 2000 underperforms S&P by >4% over 3 weeks or if 10-year yield moves < -15 bps (flight-to-quality).
  • Purchase a 1% portfolio notional SPX 1-month ATM put (or equivalent VIX-linked hedge) if VIX <14 to protect against a 5–10% tail correction; increase hedge to 2% notional if CPI prints surprise >0.4% month-on-month or Fed forward guidance turns hawkish in next 30 days.